Clinical trial
Nucleic Acid Amplification Tests (NAATs) for the Diagnosis of Pharyngeal and…
NCT00252096 · Centers for Disease Control and Prevention, U.S. Fed · Completed
Key facts
| NCT number | NCT00252096 |
|---|---|
| Title | Nucleic Acid Amplification Tests (NAATs) for the Diagnosis of Pharyngeal and Rectal Chlamydia and Gonorrhea Infections |
| Official title | Nucleic Acid Amplification Tests for the Diagnosis of Pharyngeal and Rectal Chlamydia Trachomatis and Neisseria Gonorrhoeae Infections |
| Lead sponsor | Centers for Disease Control and Prevention, U.S. Fed |
| Collaborators | University of Alabama at Birmingham |
| Status | Completed |
| Study type | Interventional |
| Conditions | Chlamydia Infections, Gonorrhea |
| Intervention type | Device |
| Interventions | Nucleic acid amplification test |
| Enrollment | 3,900 |
| Start date | Jun 1, 2003 |
| Primary completion | Jan 1, 2006 |
| Completion | Jun 1, 2010 |
| First posted | Nov 11, 2005 |
| Last update posted | Sep 27, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: